Publications

5674 Results

Randomized phase 3 study of intravenous (IV) cisplatin (CIS)/paclitaxel (PAC) versus moderately high dose IV carboplatin (CARB) followed by IV PAC and intraperitoneal (IP) CIS in optimal residual ovarian cancer (OC): An intergroup trial (GOG, SWOG, ECOG).

Authors
M Markman;B Bundy;J Benda;D Alberts;S Wadler;J Fowler;D Clark-Pearson;LF Carson
Journal / Conference
Proc of the American Society of Clinical Oncology 17:361a(#1392)
Year
1998
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9227 (GOG-114)

Docetaxel (taxotere) in extensive stage small cell lung cancer (SCLC): A phase II trial of the Southwest Oncology Group (SWOG).

Authors
HA Burris;JJ Crowley;SK Williamson;DR Gandara;RB Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 17:451a(#1737)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9242

Randomized phase III trial of cisplatin (CDDP) vs CDDP plus navelbine (NVB) in treatment of advanced non-small cell lung cancer (NSCLC): An update of a Southwest Oncology Group study (SWOG 9308).

Authors
AJ Wozniak;JJ Crowley;SP Balcerzak;GR Weiss;CH Spiridonidis;LH Baker;KS Albain;K Kelly;SA Taylor;DR Gandara;RB Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 17:453a(#1744)
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9308

Androgen deprivation (AD) + 4-courses of fixed-schedule suramin in D2 prostate cancer (PCA) patients (pts): A Southwest Oncology Group phase II study.

Authors
M Hussain;E Fisher;D Wood;E Small;M Eisenberger;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 17:314a(#1211)
Year
1998
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9343

Analysis of suramin (S) levels obtained from D2 hormone naive prostate cancer (HNPCA) patients (pts) treated with fixed bolus suramin: A Southwest Oncology Group study.

Authors
DP Petrylak;JO Connor;E Fisher;M Eisenberger;ED Crawford;M Hussain
Journal / Conference
Proc of the American Society of Clinical Oncology 17:340a(#1310)
Year
1998
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9343

Initial report of the SWOG biological correlative study of C-ERBB-2 expression as a predictor of outcome in a trial comparing adjuvant CAF T with tamoxifen (T) alone.

Authors
PM Ravdin;S Green;KS Albain;V Boucher;J Ingle;K Pritchard;L Shepard;N Davidson;DF Hayes;GM Clark;S Martino;CK Osborne;DC Allred
Journal / Conference
Proc of the American Society of Clinical Oncology 17:97a(#374)
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9445

A phase II study of standard dose daunomycin and cytosine arabinoside (ARA-C) with high dose ARA-C induction therapy followed by sequential high dose ARA-C consolidation for adults with previously untreated acute myelogenous leukemia: A Southwest Oncology Group study (SWOG 9500).

Authors
S Petersdorf;C Rankin;H Terebelo;D Head;F Appelbaum
Journal / Conference
Proc of the American Society of Clinical Oncology 17:15a(#55)
Year
1998
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9500

SWOG 9518: Phase II trial of continuous infusion topotecan in patients (pts) with advanced soft tissue sarcomas (sts).

Authors
C Rankin;GT Budd;L Hutchins;K Antman
Journal / Conference
Proc of the American Society of Clinical Oncology 17:523a(#2011)
Year
1998
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-9518

Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.

Authors
MA Eisenberger;BA Blumenstein;ED Crawford;G Miller;DG McLeod;PJ Loehrer;G Wilding;K Sears;DJ Culkin;IM Thompson Jr;AJ Bueschen;BA Lowe
Journal / Conference
New England Journal of Medicine 339:1036-1042
Year
1998
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide and radiation for poor-risk stage III non-small cell lung cancer.

Authors
DH Lau;JJ Crowley;DR Gandara;MB Hazuka;KS Albain;B Leigh;WS Fletcher;KS Lanier;LW Keiser;RB Livingston
Journal / Conference
Journal of Clinical Oncology 16(9):3078-3081
Year
1998
Research Committee(s)
Lung
Study Number(s)
SWOG-9429